羊水栓塞と医療による分娩誘導:人口ベースのコホート研究
Michael S Kramer1, Jocelyn Rouleau, Thomas F Baskett
1Department of Paediatrics and Department of Epidemiology and Biostatistics, McGill University Faculty of Medicine, Montreal, QC, Canada. michael.kramer@mcgill.ca
Lancet (London, England)
|October 24, 2006
まとめ
医療による出産誘導は,まれだが深刻な合併症である胎児液栓塞のリスクを高めるようです. この発見は,選択的労働誘導に関する情報に基づいた意思決定にとって重要である.
科学分野:
- 産婦人科と産婦人科を担当しています.
- 妊産婦・胎児医学について
- エピデミオロジー エピデミオロジー
背景:
- 排卵液栓塞 (AFE) は,未知の病因で発生する,希少で重症で,しばしば致命的な母性出産合併症です.
- AFEの潜在的な危険因子の調査は,母子のアウトカムを改善するために不可欠です.
研究 の 目的:
- 医療による分娩誘導と胎児液栓塞のリスクとの関連を調査する.
- AFEに関連する他の要因を評価するために,母親の年齢と出産の合併症を含む.
主な方法:
- 1991年から2002年の間にカナダの病院で出産した300万人の集団ベースのコホート研究です.
- 医学的および外科的誘導,母親の年齢,およびその他の産科的要因に関連してAFEの全体的および致死率の分析.
主要な成果:
- 医療による出産誘導は,全胎動脈栓塞のほぼ2倍のリスクと関連していた (調整されたオッズ比1.8).
- 医療誘導とAFEの関連性は,致死者に対してより強く見られた (粗略な確率比3.5).
- AFEのリスクの増加は,母親の高齢化,帝王切開/器用分娩,および様々な妊娠/分娩合併症とも関連していました.
結論:
- 医療による分娩誘導は,子宮液栓塞の危険因子であるようです.
- 絶対的な過剰リスクは低いが,この関連性の認識は,選択的労働誘導に関する臨床的意思決定に重要である.
関連する概念動画
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...